Octapharma USA, Inc.
Octapharma USA, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy | Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy | Recruiting | Phase 2 | 2026-08-05 | NCT06599697 | |
| IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies | Small Fiber Neuropathy, nervous system disorder, neuritis, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 2 | 2026-01-09 | NCT04153422 |